RT Journal Article
SR Electronic
T1 Coronavirus Disease 2019 (COVID-19): An Evidence Map of Medical Literature
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.07.20093674
DO 10.1101/2020.05.07.20093674
A1 Liu, Nan
A1 Chee, Marcel Lucas
A1 Niu, Chenglin
A1 Pek, Pin Pin
A1 Siddiqui, Fahad Javaid
A1 Ansah, John Pastor
A1 Matchar, David Bruce
A1 Lam, Sean Shao Wei
A1 Abdullah, Hairil Rizal
A1 Chan, Angelique
A1 Malhotra, Rahul
A1 Graves, Nicholas
A1 Koh, Mariko Siyue
A1 Yoon, Sungwon
A1 Ho, Andrew Fu Wah
A1 Ting, Daniel Shu Wei
A1 Low, Jenny Guek Hong
A1 Ong, Marcus Eng Hock
YR 2020
UL http://medrxiv.org/content/early/2020/05/11/2020.05.07.20093674.abstract
AB Since the beginning of the COVID-19 outbreak in December 2019, a substantial body of COVID-19 medical literature has been generated. As of May 2020, gaps in the existing literature remain unidentified and, hence, unaddressed. In this paper, we summarise the medical literature on COVID-19 between 1 January and 24 March 2020 using evidence maps and bibliometric analysis in order to systematically identify gaps and propose areas for valuable future research. The examined COVID-19 medical literature originated primarily from Asia and focussed mainly on clinical features and diagnosis of the disease. Many areas of potential research remain underexplored, such as mental health research, the use of novel technologies and artificial intelligence, research on the pathophysiology of COVID-19 within different body systems, and research on indirect effects of COVID-19 on the care of non-COVID-19 patients. Research collaboration at the international level was limited although improvements may aid global containment efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Duke-NUS Signature Research Programme funded by the Ministry of Health, Singapore.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.